Ezetimibe/Rosuvastatin Calcium
- Generic Name
- Ezetimibe/Rosuvastatin Calcium
A Study to Evaluate the Drug-drug Interaction and Safety Between HCP1306, RLD2302 and RLD2102 in Healthy Volunteers
- First Posted Date
- 2024-07-24
- Last Posted Date
- 2025-02-20
- Lead Sponsor
- Hanmi Pharmaceutical Company Limited
- Target Recruit Count
- 66
- Registration Number
- NCT06518122
- Locations
- π°π·
Jeonbuk National University Hospital, Jeonju, Jeollabuk-do, Korea, Republic of
A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination and Co-Administration of HGP0904, HGP0608 and HCP1306 Tablets in Healthy Male Subjects.
- First Posted Date
- 2020-03-26
- Last Posted Date
- 2020-03-26
- Lead Sponsor
- Hanmi Pharmaceutical Company Limited
- Target Recruit Count
- 61
- Registration Number
- NCT04322266
- Locations
- π°π·
Korea University Hospital (Anam), Seoul, Korea, Republic of
A Study to Evaluate the Pharmacokinetic and Pharmacodynamic Interactions Between HGP0904, HGP0608, and HCP1306 in Healthy Male Subjects.
- First Posted Date
- 2019-09-09
- Last Posted Date
- 2019-09-09
- Lead Sponsor
- Hanmi Pharmaceutical Company Limited
- Target Recruit Count
- 31
- Registration Number
- NCT04081844
- Locations
- π°π·
Korea University Hospital (Anam), Seoul, Korea, Republic of
Evaluate the Pharmacokinetics and Safety of HCP1306 and Co-administration of HGP0816, HGP1404 in Healthy Male Volunteers
Phase 1
Completed
- Conditions
- Primary Hypercholesterolemia
- Interventions
- First Posted Date
- 2016-10-21
- Last Posted Date
- 2016-10-21
- Lead Sponsor
- Hanmi Pharmaceutical Company Limited
- Target Recruit Count
- 60
- Registration Number
- NCT02941848
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
Β© Copyright 2025. All Rights Reserved by MedPath